autologous ade1- latent membrane protein ctls
Cell therapyexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2008 (NCT00779337)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous ade1- latent membrane protein ctls
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00779337 | Phase 1 | Oct 1, 2008 | Australian Department of Industry, Tourism and Resources, British Society for Haematology, National Health and Medical Research Council, Australia, The Atlantic Philanthropies, University of Queensland |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Australian Department of Industry, Tourism and Resources | Government | 1 | 0 | 1 | 2008 |
| British Society for Haematology | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Health and Medical Research Council, Australia | Government | 1 | 0 | 1 | 2008 |
| The Atlantic Philanthropies | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Queensland | Academic/Hospital | 1 | 1 | 1 | 2008 |
5 organizations
Page 1 / 1